Ovarian cancer is one of the most deadly forms of gynecological cancer, often termed a “silent killer” due to its vague symptoms and late diagnosis
About
Ovarian cancer occurs when abnormal cells in ovaries or fallopian tubes grow and multiply out of control.
Ovariesare part of the female reproductive system. These two round, walnut-sized organs make eggs during reproductive years.
Cancer Subtypes:
Type I Tumors: Less common, typically diagnosed early, and have a better prognosis.
Type II Tumors: More aggressive, commonly diagnosed at advanced stages, and responsible for most deaths.
Common Symptoms: Include bloating, pelvic or abdominal pain, loss of appetite, feeling full quickly, frequent urination, indigestion, constipation, back pain, fatigue, weight loss, and postmenopausal bleeding.
Diagnostic Challenges: These symptoms often mimic less serious conditions, leading to delayed diagnosis. A 2004 study noted that women with malignant ovarian cancer experience these symptoms 20-30 times a month, more severely compared to those without the disease.
Screening Challenges: There are no effective routine screening tests for ovarian cancer. The CA125 blood test is not recommended for general screening due to its low specificity and potential for false positives.
Risk Factors
Genetics: BRCA1 and BRCA2 Mutations significantly increase the risk of ovarian cancer (up to 50% for BRCA1 and around 15% for BRCA2).
Endometriosis: Women with endometriosis have a higher risk of developing certain types of ovarian cancer, though the risk is relatively low.
Hormone Replacement Therapy (HRT), used for menopausal symptoms, has been associated with a higher risk of ovarian cancer, even with short-term use.
Unhealthy lifestyle
The Gravity of Ovarian Cancer
Prevalence in India: Ovarian cancer ranks among the top three cancers in Indian women, contributing to 6.6% of all female cancer cases.
Incidence and Mortality: In 2022, India reported 47,333 new cases and 32,978 deaths due to ovarian cancer.